What problem does this paper attempt to address?

The main issue this paper attempts to address is the prevention of Postpartum Depression (PPD). Specifically, the study aims to evaluate the efficacy and safety of Dexmedetomidine in the early prevention of postpartum depression after cesarean section, particularly in women who already have depression during pregnancy. ### Research Background Postpartum depression is one of the most common psychological disorders in women after childbirth, with an incidence rate of about 10% to 20%. Due to the severe negative impacts of postpartum depression on mothers, infants, family members, and society, finding effective prevention and treatment methods has become a public health priority. Although there are currently some screening and intervention measures that can reduce depressive symptoms, there is a lack of effective pharmacological prevention strategies. ### Research Objectives The main objective of this study is to evaluate the efficacy and safety of Dexmedetomidine in the early prevention of postpartum depression after cesarean section. Specific goals include: 1. Assessing the effect of Dexmedetomidine in the early prevention of postpartum depression after cesarean section. 2. Comparing the differences in postoperative pain and sleep quality between the Dexmedetomidine group and the control group. 3. Analyzing the impact of Dexmedetomidine on plasma brain-derived neurotrophic factor (BDNF) and precursor BDNF (pro-BDNF) levels. ### Research Methods This is a randomized, double-blind, placebo-controlled clinical trial that recruited 338 women with an Edinburgh Postnatal Depression Scale (EPDS) score greater than 9 who underwent cesarean section in two hospitals in Hunan, China. Participants were randomly assigned to the Dexmedetomidine group or the control group. The Dexmedetomidine group received an intravenous injection of 0.5 μg/kg of Dexmedetomidine within 10 minutes after delivery, while the control group received an equal amount of saline. Both groups received patient-controlled intravenous analgesia (PCIA) within 48 hours postoperatively, with the Dexmedetomidine group continuing to use Dexmedetomidine plus sufentanil, and the control group using only sufentanil. ### Main Results 1. **Postpartum Depression Screening Positive Rate**: At 7 days and 42 days postpartum, the positive screening rate for postpartum depression was significantly lower in the Dexmedetomidine group compared to the control group (7 days: 12.6% vs 32.1%, risk ratio 0.39; 42 days: 11.4% vs 30.3%, risk ratio 0.38). 2. **Suicidal Ideation**: The incidence of suicidal ideation at 7 days postpartum was significantly lower in the Dexmedetomidine group compared to the control group, but there was no significant difference at 42 days. 3. **Pain Scores**: The resting pain scores at 6 hours, 24 hours, and 48 hours postoperatively were significantly lower in the Dexmedetomidine group compared to the control group. 4. **Sleep Quality**: The Insomnia Severity Index (ISI) scores at 1 day and 2 days postoperatively were significantly lower in the Dexmedetomidine group compared to the control group. 5. **Plasma BDNF and pro-BDNF Levels**: Plasma BDNF levels were significantly increased, while pro-BDNF levels were significantly decreased in the Dexmedetomidine group. ### Safety Evaluation There was no significant difference in the incidence of adverse events between the Dexmedetomidine group and the control group, but the incidence of hypotension was significantly higher in the Dexmedetomidine group. ### Conclusion This study indicates that the early preventive use of Dexmedetomidine after cesarean section can significantly reduce the positive screening rate for postpartum depression, improve postoperative pain and sleep quality, and has good safety. The antidepressant effect of Dexmedetomidine may be related to its upregulation of plasma BDNF levels and downregulation of pro-BDNF levels.

Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression

Efficacy Of Dexmedetomidine As A Neuraxial Adjuvant For Elective Cesarean Sections: A Meta-Analysis Of Randomized Trials

Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial.

Perioperative intravenous infusion of dexmedetomidine for alleviating postpartum depression after cesarean section: A meta -analysis and systematic review

Esketamine for Postpartum Depression Among Women Undergoing Cesarean Delivery

Impact of Intraoperative Infusion and Postoperative PCIA of Dexmedetomidine on Early Breastfeeding After Elective Cesarean Section: A Randomized Double-Blind Controlled Trial

Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study

The effect of a subclinical dose of esketamine on depression and pain after cesarean section: A prospective, randomized, double-blinded controlled trial

Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study

Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial

Effect of dexmedetomidine on oxytocin-induced uterine contraction during optimal caesarean section anaesthesia

Dexmedetomidine for Antiemesis in Gynecologic Surgery: a Meta-Analysis of Randomized Controlled Trials.

Dexmedetomidine improves intraoperative conditions and quality of postoperative analgesia when added to epidural in elective cesarean section

Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial

The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical Studies

The effect of ketamine on preventing postpartum depression

Single Low-Dose Ketamine Infusion for Women with Prenatal Depressive Symptoms Undergoing Cesarean Delivery: A Pilot Randomized Trial

Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail

Impact Of Dexmedetomidine On The Incidence Of Delirium In Elderly Patients After Cardiac Surgery: A Randomized Controlled Trial

Efficacy of dexmedetomidine in suppressing cardiovascular and hormonal responses to general anaesthesia for caesarean delivery: a dose-response study

Effect of intraoperative dexmedetomidine on recovery of gastrointestinal function after caesarean section undergoing spinal and epidural anesthesia: A randomized, double blind, placebo-controlled clinical trial